Insights from a National Database for Programs Supporting Neuropsychiatric Symptoms of Dementia in Australia

Overview

Journal Gerontology

Specialty Geriatrics

Date 2024 May 14

PMID 38744262

Authors

Mustafa Atee

Thomas Morris

Daniel Whiting

Stephen Macfarlane

Marie Alford

Affiliations

Soon will be listed here.

Citing Articles

Psychotropic Polypharmacy in Dementia: A Retrospective Analysis for People with Neuropsychiatric Symptoms Referred to an Australian Dementia Support Service.

Atee M, Stafford A, Whiting D, Lee Y, Morrow C, Nyakaboyi G Drugs Aging. 2025; 42(2):165-175.

PMID: 39838223 PMC: 11799070. DOI: 10.1007/s40266-024-01177-y.

References

Macfarlane S, Atee M, Morris T, Whiting D, Healy M, Alford M . Evaluating the Clinical Impact of National Dementia Behaviour Support Programs on Neuropsychiatric Outcomes in Australia. Front Psychiatry. 2021; 12:652254. PMC: 8076549. DOI: 10.3389/fpsyt.2021.652254. View

Wood S, Cummings J, Hsu M, Barclay T, Wheatley M, Yarema K . The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry. 2000; 8(1):75-83. DOI: 10.1097/00019442-200002000-00010. View

Johnston B, Narayanasamy M . Exploring psychosocial interventions for people with dementia that enhance personhood and relate to legacy- an integrative review. BMC Geriatr. 2016; 16:77. PMC: 4820853. DOI: 10.1186/s12877-016-0250-1. View

Jennum P, Baandrup L, Ibsen R, Kjellberg J . Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: A population-based register study. Eur Neuropsychopharmacol. 2015; 25(11):1906-13. DOI: 10.1016/j.euroneuro.2015.08.014. View

Schaller S, Mauskopf J, Kriza C, Wahlster P, Kolominsky-Rabas P . The main cost drivers in dementia: a systematic review. Int J Geriatr Psychiatry. 2014; 30(2):111-29. DOI: 10.1002/gps.4198. View